id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-305283-1bg1ykui	ElSeirafi, Mohamed MA.	Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases	2020-06-23		.txt	text/plain	1906	130	51	We had experience in treating five critically ill patients with severe lung injury who were COVID-19 positive with tocilizumab. We had experience in treating five critically ill patients with severe lung injury who were COVID-19 positive with tocilizumab. The patient improved significantly on the third day following tocilizumab injection and rt-PCR test for COVID-19 was negative on the fourth day. Nasopharyngeal swab for COVID-19 was positive and the patient was initiated on oral hydroxychloroquine 200 mg twice daily along with ceftriaxone, piperacillin/tazobactam, aizthromycin, ribavirin, pegylated interferon (received single dose) and plasma therapy (two doses). Patient improved the following day with a negative COVID-19 test results twice on alternate days and the patient was discharge from ICU. We observed in the present study that COVID-19 patients with severe lung injury responded dramatically following the introduction of tocilizumab. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in	./cache/cord-305283-1bg1ykui.txt	./txt/cord-305283-1bg1ykui.txt